Annual Total Liabilities
$17.63 M
+$3.91 M+28.47%
December 31, 2023
Summary
- As of February 7, 2025, EVAX annual total liabilities is $17.63 million, with the most recent change of +$3.91 million (+28.47%) on December 31, 2023.
- During the last 3 years, EVAX annual total liabilities has risen by +$12.70 million (+257.78%).
- EVAX annual total liabilities is now at all-time high.
Performance
EVAX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$15.19 M
+$1.21 M+8.63%
September 1, 2024
Summary
- As of February 7, 2025, EVAX quarterly total liabilities is $15.19 million, with the most recent change of +$1.21 million (+8.63%) on September 1, 2024.
- Over the past year, EVAX quarterly total liabilities has increased by +$509.00 thousand (+3.47%).
- EVAX quarterly total liabilities is now -32.97% below its all-time high of $22.65 million, reached on March 31, 2024.
Performance
EVAX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EVAX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.5% | +3.5% |
| 3 y3 years | +257.8% | +96.5% |
| 5 y5 years | +86.7% | +208.2% |
EVAX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +128.2% | -33.0% | +96.5% |
| 5 y | 5-year | at high | +923.7% | -33.0% | +781.8% |
| alltime | all time | at high | +4318.1% | -33.0% | +781.8% |
Evaxion Biotech A/S Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.19 M(+8.6%) |
| Jun 2024 | - | $13.98 M(-38.3%) |
| Mar 2024 | - | $22.65 M(+28.5%) |
| Dec 2023 | $17.63 M(+28.5%) | $17.63 M(+20.1%) |
| Sep 2023 | - | $14.68 M(+3.2%) |
| Jun 2023 | - | $14.22 M(+2.2%) |
| Mar 2023 | - | $13.91 M(+1.4%) |
| Dec 2022 | $13.72 M | $13.72 M(-1.3%) |
| Sep 2022 | - | $13.90 M(+0.3%) |
| Jun 2022 | - | $13.85 M(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $14.69 M(+90.2%) |
| Dec 2021 | $7.73 M(+56.8%) | $7.73 M(+3.5%) |
| Sep 2021 | - | $7.47 M(+28.1%) |
| Jun 2021 | - | $5.83 M(-18.2%) |
| Mar 2021 | - | $7.12 M(+44.5%) |
| Dec 2020 | $4.93 M(+186.1%) | $4.93 M(+46.1%) |
| Sep 2020 | - | $3.37 M(+95.8%) |
| Dec 2019 | $1.72 M(-81.8%) | $1.72 M |
| Dec 2018 | $9.44 M(+2266.9%) | - |
| Dec 2017 | $399.00 K | - |
FAQ
- What is Evaxion Biotech A/S annual total liabilities?
- What is the all time high annual total liabilities for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual total liabilities year-on-year change?
- What is Evaxion Biotech A/S quarterly total liabilities?
- What is the all time high quarterly total liabilities for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S quarterly total liabilities year-on-year change?
What is Evaxion Biotech A/S annual total liabilities?
The current annual total liabilities of EVAX is $17.63 M
What is the all time high annual total liabilities for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual total liabilities is $17.63 M
What is Evaxion Biotech A/S annual total liabilities year-on-year change?
Over the past year, EVAX annual total liabilities has changed by +$3.91 M (+28.47%)
What is Evaxion Biotech A/S quarterly total liabilities?
The current quarterly total liabilities of EVAX is $15.19 M
What is the all time high quarterly total liabilities for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly total liabilities is $22.65 M
What is Evaxion Biotech A/S quarterly total liabilities year-on-year change?
Over the past year, EVAX quarterly total liabilities has changed by +$509.00 K (+3.47%)